Clinical Trial Update: Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing Avastin (bevacizumab) added to ABVD chemotherapy for advanced-stage Hodgkin lymphoma was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Avastin (bevacizumab)
• Bleomycin (bleomycin)
• Dacarbazine (dacarbazine)
• Vinblastine (vinblastine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hodgkin Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-04-28